CAS No. |
514-36-3 |
|---|---|
英文名称 |
2-((8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate |
别名 |
17-dihydroxy-20-dion(11-beta)-pregn-4-ene-21-(acetyloxy)-9-fluoro-11;20-dione,9-fluoro-11-beta,17,21-trihydroxy-pregn-4-ene-21-acetate;9-alpha-fluorohydrocortisone-21-acetate;9-alpha-fluorohydrocortisoneacetate;9-fluoro-11-beta,17,21-trihydroxypregn-4-ene-3,20-dione21-acetate;9-fluoro-17-hydroxy-corticosteron21-acetate;FLUDROCORTISONEACETATE,MICRONIZED,USP;9α-Fluoro-11β,17α,21-trihydroxypregn-4-ene-3,20-dione 21-acetate |
标准英文名 |
2-((8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate |
分子式 |
C23H31FO6 |
分子量 |
422.49 |
精确分子量 |
422.21 |
SMILES |
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C |
标准SMILES |
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C |
用途 |
Fludrocortisone acetate is the only mineralocorticoid recommended by U.S. clinical guidelines for the treatment of salt-wasting congenital adrenal hyperplasia and Addison's disease. It is primarily used for its mineralocorticoid activity in primary adrenal insufficiency and can be combined with glucocorticoids for replacement therapy. It is also indicated for conditions such as hypoaldosteronism with low renin, and orthostatic hypotension caused by autonomic neuropathy. |
InChIKey |
SYWHXTATXSMDSB-GSLJADNHSA-N |
|
|
评论 |
|---|